{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:27:19Z","timestamp":1776767239713,"version":"3.51.2"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051960","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T01:44:44Z","timestamp":1356140684000},"page":"e51960","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Efficacy, Safety and Anticancer Activity of Protein Nanoparticle-Based Delivery of Doxorubicin through Intravenous Administration in Rats"],"prefix":"10.1371","volume":"7","author":[{"given":"Kishore","family":"Golla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Cherukuvada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand K.","family":"Kondapi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer worldwide incidence and trends","volume":"127","author":"FX Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"ref2","first-page":"74","article-title":"Global cancer statistics, 2002, CA CancerJ","volume":"55","author":"DM Parkin","year":"2002","journal-title":"Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"HI Yang","year":"2002","journal-title":"NEJM"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(89)91016-7","article-title":"Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma","volume":"2","author":"M Colombo","year":"1989","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics","volume":"46","author":"M Varela","year":"2007","journal-title":"J Hepatology"},{"key":"ref6","first-page":"2892","article-title":"Hepatocellularcarcinoma: the need forprogress","volume":"23","author":"MB Thomas","year":"2005","journal-title":"J ClinOncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Barcelona Liver Cancer Group: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"JM Llovet","year":"2002","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000227142","article-title":"A phase 2 study of cisplatin in patients with hepatocellular carcinoma","volume":"50","author":"S Okada","year":"1993","journal-title":"Oncology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5","article-title":"Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial","volume":"42","author":"G Falkson","year":"1978","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/1097-0142(20000901)89:5<983::AID-CNCR7>3.0.CO;2-G","article-title":"Comparison of 2methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species","volume":"89","author":"HL Lin","year":"2000","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/17425247.5.2.205","article-title":"Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug","volume":"5","author":"I Hamad","year":"2008","journal-title":"ExpertOpin Drug Deliv"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarteriallipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"CM Lo","year":"2002","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Z Xu","year":"2009","journal-title":"Biomaterials"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.biomaterials.2011.10.050","article-title":"Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types","volume":"33","author":"S Bae","year":"2011","journal-title":"Biomaterials"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1478-3231.2006.01316.x","article-title":"Expression of iron regulatory genes in a rat model of hepatocellular carcinoma","volume":"26","author":"P Holmstr\u00f6m","year":"2006","journal-title":"Liver Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00432-009-0585-5","article-title":"Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications","volume":"135","author":"HH Tseng","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e7240","DOI":"10.1371\/journal.pone.0007240","article-title":"An Efficient Targeted Drug Delivery through Apotransferrin Loaded Nanoparticles","volume":"4","author":"ADS Krishna","year":"2009","journal-title":"PLoS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bj2370163","article-title":"Uptake and subcellular processing of 59Fe-125I-labelled transferrin by rat liver","volume":"237","author":"EH Morgan","year":"1986","journal-title":"Biochem J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24572","article-title":"Hepatocytes internalize trophic receptors at large endocytic \u201cHot Spots\u201d","volume":"54","author":"H Cao","year":"2011","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1073\/pnas.95.3.1148","article-title":"Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport","volume":"95","author":"MD Fleming","year":"1998","journal-title":"ProcNatlAcadSci U S A"},{"key":"ref21","first-page":"32141","article-title":"ZRT\/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron through transferrin","volume":"285","author":"N Zhao","year":"2010","journal-title":"J BiolChem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ja01207a034","article-title":"Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids","volume":"68","author":"EJ Cohn","year":"1964","journal-title":"J Am Chem Soc"},{"key":"ref23","first-page":"303","article-title":"Three-dimensional structure of mare diferriclactoferrin at 2.6Aresolution. J. Mol","volume":"289","author":"AK Sharma","year":"1999","journal-title":"Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nano.2007.08.002","article-title":"Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin","volume":"3","author":"J Zhang","year":"2007","journal-title":"Nanomedicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2005.02.045","article-title":"Doxorubicincoupled to lactosaminatedalbumininhibits the growth of hepatocellularcarcinomasinduced in rats by diethylnitrosamine","volume":"43","author":"L Fiume","year":"2005","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1073\/pnas.70.7.1968","article-title":"Structure-Function Relationships in Lactate Dehydrogenase ,","volume":"70","author":"M Adams","year":"1973","journal-title":"ProcNatlAcadSci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0304-4165(85)90182-5","article-title":"Theselenoenzyme phospholipid hydroperoxide glutathione peroxidase","volume":"839","author":"E Ursini","year":"1985","journal-title":"Biochem Biophys Acta"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cbi.2009.10.011","article-title":"Efficacy of lanreotide in preventing the occurrence of chemically induced hepatocellular carcinoma in rats","volume":"183","author":"I Borbath","year":"2010","journal-title":"ChemBiol Interact"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2006.09.007","article-title":"Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer","volume":"116","author":"HL Wong","year":"2006","journal-title":"J Control Release"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1016\/j.biomaterials.2004.11.014","article-title":"In vitro study of anticancer drug doxorubicin in PLGA-based microparticles","volume":"26","author":"R Lina","year":"2005","journal-title":"Biomaterials"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1081\/CNV-100103136","article-title":"Pegylated liposomal doxorubicin: Metamorphosis of anold drug into a new form of chemotherapy","volume":"19","author":"A Gabizon","year":"2001","journal-title":"Cancer investigation"},{"key":"ref32","first-page":"98","article-title":"Prolongedcirculation time and enhanced accumulation in malignant exudatesof doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"A Gabizon","year":"1994","journal-title":"Cancer Res"},{"key":"ref33","unstructured":"SheelaA, AbrahamDN,WaterhouseLD,Mayer PRC, Thomas DM, <etal>et al<\/etal>..(2003) Liposomal formulation of doxorubicin. In D. Nejat (ed.),Methods in enzymology, vol. 391. Academic press 71\u201397."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2006.07.012","article-title":"Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug","volume":"116","author":"F Ahmed","year":"2006","journal-title":"J Contr Release"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jconrel.2005.06.013","article-title":"Novel biomimetic polymersomes as polymer therapeutics for drug delivery","volume":"107","author":"JP Xu","year":"2005","journal-title":"J Contr Release"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2008.03.007","article-title":"Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26","volume":"128","author":"Z Pang","year":"2008","journal-title":"J Contr Release"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.biomaterials.2009.12.043","article-title":"The intracellular drug delivery and antitumor activity of doxorubicin loaded poly(\u03b3-benzyl L-glutamate)-bhyaluronanpolymersomes","volume":"10","author":"KK Upadhyay","year":"2010","journal-title":"Biomaterials"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(99)00133-9","article-title":"Doxorubicin-loaded poly (ethylene glycol)-poly([beta]-benzyl\u2013aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance","volume":"64","author":"K Kataoka","year":"2000","journal-title":"J Contr Release"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-3659(00)00340-0","article-title":"Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer","volume":"70","author":"HS Yooand","year":"2001","journal-title":"J Contr Release"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jconrel.2004.06.003","article-title":"Micellar carriers based on block copolymers of poly([var epsilon]-caprolactone) and poly(ethylene glycol) for doxorubicin delivery","volume":"98","author":"X Shuai","year":"2004","journal-title":"J Contr Release"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/phrs.2000.0695","article-title":"Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats","volume":"42","author":"A Fundar\u00f2","year":"2000","journal-title":"Pharmacol Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860290031868","article-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues","volume":"10","author":"GP Zara","year":"2002","journal-title":"J Drug Target"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2009.10.003","article-title":"Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice","volume":"142","author":"AM Al-Abd","year":"2010","journal-title":"J Control Release"},{"key":"ref44","unstructured":"Schneider Y, Abarca J, Aboud-Pirak E, Baurain R, Ceulemans F, <etal>et al<\/etal>.. (1984) Drug targeting in human cancerchemotherapy. In: Gregoriadis G, Poste G, Senior J, Trouet A, editors. Receptor-mediated targeting of drugs. NATO ASI series A: life sciences 1\u201325."},{"key":"ref45","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2005.02.045","article-title":"Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine","volume":"43","author":"L Fiume","year":"2005","journal-title":"J Hepatology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-3659(97)00115-6","article-title":"Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor","volume":"50","author":"M Yokoyama","year":"1998","journal-title":"J Control Release"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sct.1989.5.1","article-title":"Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases","volume":"5","author":"N Chiannilkulchai","year":"1989","journal-title":"Sel Cancer Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02897257","article-title":"Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice","volume":"l26","author":"N Chiannilkulchai","year":"1990","journal-title":"Cancer Chemother Pharmaco"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02940287","article-title":"Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles","volume":"26","author":"C Verdun","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejpb.2012.03.009","article-title":"Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticles","volume":"81","author":"K Alhareth","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/phrs.1999.0509","article-title":"Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)","volume":"40","author":"GP Zara","year":"1999","journal-title":"Pharmacol Res"},{"key":"ref52","first-page":"22669705","article-title":"In Vivo Evaluation of Doxorubicin-Loaded (PEG)(3)-PLA Nanopolymersomes (PolyDoxSome) Using DMBA-Induced Mammary Carcinoma Rat Model and Comparison with Marketed LipoDox\u2122","author":"WY Ayen","year":"2012","journal-title":"Pharm Res PMID"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2009.01.023","article-title":"Targeted delivery of doxorubicin using stealth liposomes modified with transferrin","volume":"373","author":"X Li","year":"2009","journal-title":"Int J Pharm"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T13:58:26Z","timestamp":1562507906000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051960"}},"subtitle":[],"editor":[{"given":"Devanand","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051960","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}